Scolaris Content Display Scolaris Content Display

Forest plot of comparison: 3 Death at five years, outcome: 3.1 Head and neck cancer.
Figuras y tablas -
Figure 1

Forest plot of comparison: 3 Death at five years, outcome: 3.1 Head and neck cancer.

Comparison 1 Death at one year, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 1.1

Comparison 1 Death at one year, Outcome 1 Head and neck cancer.

Comparison 1 Death at one year, Outcome 2 Head and neck ‐ best case scenario.
Figuras y tablas -
Analysis 1.2

Comparison 1 Death at one year, Outcome 2 Head and neck ‐ best case scenario.

Comparison 1 Death at one year, Outcome 3 Head and neck ‐ worst case scenario.
Figuras y tablas -
Analysis 1.3

Comparison 1 Death at one year, Outcome 3 Head and neck ‐ worst case scenario.

Comparison 1 Death at one year, Outcome 4 Uterine cervix cancer.
Figuras y tablas -
Analysis 1.4

Comparison 1 Death at one year, Outcome 4 Uterine cervix cancer.

Comparison 1 Death at one year, Outcome 5 Uterine cervix ‐ best case scenario.
Figuras y tablas -
Analysis 1.5

Comparison 1 Death at one year, Outcome 5 Uterine cervix ‐ best case scenario.

Comparison 1 Death at one year, Outcome 6 Uterine cervix ‐ worst case scenario.
Figuras y tablas -
Analysis 1.6

Comparison 1 Death at one year, Outcome 6 Uterine cervix ‐ worst case scenario.

Comparison 1 Death at one year, Outcome 7 Urinary bladder cancer.
Figuras y tablas -
Analysis 1.7

Comparison 1 Death at one year, Outcome 7 Urinary bladder cancer.

Comparison 1 Death at one year, Outcome 8 Urinary bladder ‐ best case scenario.
Figuras y tablas -
Analysis 1.8

Comparison 1 Death at one year, Outcome 8 Urinary bladder ‐ best case scenario.

Comparison 1 Death at one year, Outcome 9 Urinary bladder ‐ worst case scenario.
Figuras y tablas -
Analysis 1.9

Comparison 1 Death at one year, Outcome 9 Urinary bladder ‐ worst case scenario.

Comparison 1 Death at one year, Outcome 10 Bronchial cancer.
Figuras y tablas -
Analysis 1.10

Comparison 1 Death at one year, Outcome 10 Bronchial cancer.

Comparison 1 Death at one year, Outcome 11 Rectal cancer.
Figuras y tablas -
Analysis 1.11

Comparison 1 Death at one year, Outcome 11 Rectal cancer.

Comparison 1 Death at one year, Outcome 12 Oesphageal cancer.
Figuras y tablas -
Analysis 1.12

Comparison 1 Death at one year, Outcome 12 Oesphageal cancer.

Comparison 1 Death at one year, Outcome 13 Gliobastoma.
Figuras y tablas -
Analysis 1.13

Comparison 1 Death at one year, Outcome 13 Gliobastoma.

Comparison 2 Death at two years, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 2.1

Comparison 2 Death at two years, Outcome 1 Head and neck cancer.

Comparison 2 Death at two years, Outcome 2 Head and neck ‐ best case scenario.
Figuras y tablas -
Analysis 2.2

Comparison 2 Death at two years, Outcome 2 Head and neck ‐ best case scenario.

Comparison 2 Death at two years, Outcome 3 Head and neck ‐ worst case scenario.
Figuras y tablas -
Analysis 2.3

Comparison 2 Death at two years, Outcome 3 Head and neck ‐ worst case scenario.

Comparison 2 Death at two years, Outcome 4 Uterine cervix cancer.
Figuras y tablas -
Analysis 2.4

Comparison 2 Death at two years, Outcome 4 Uterine cervix cancer.

Comparison 2 Death at two years, Outcome 5 Urinary bladder carcinoma.
Figuras y tablas -
Analysis 2.5

Comparison 2 Death at two years, Outcome 5 Urinary bladder carcinoma.

Comparison 2 Death at two years, Outcome 6 Urinary bladder ‐ best case.
Figuras y tablas -
Analysis 2.6

Comparison 2 Death at two years, Outcome 6 Urinary bladder ‐ best case.

Comparison 2 Death at two years, Outcome 7 Urinary bladder ‐ worst case.
Figuras y tablas -
Analysis 2.7

Comparison 2 Death at two years, Outcome 7 Urinary bladder ‐ worst case.

Comparison 3 Death at five years, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 3.1

Comparison 3 Death at five years, Outcome 1 Head and neck cancer.

Comparison 3 Death at five years, Outcome 2 Head and neck ‐ best case scenario.
Figuras y tablas -
Analysis 3.2

Comparison 3 Death at five years, Outcome 2 Head and neck ‐ best case scenario.

Comparison 3 Death at five years, Outcome 3 Head and neck ‐ worst case scenario.
Figuras y tablas -
Analysis 3.3

Comparison 3 Death at five years, Outcome 3 Head and neck ‐ worst case scenario.

Comparison 3 Death at five years, Outcome 4 Uterine cervix cancer.
Figuras y tablas -
Analysis 3.4

Comparison 3 Death at five years, Outcome 4 Uterine cervix cancer.

Comparison 3 Death at five years, Outcome 5 Uterine cancer ‐ best case scenario.
Figuras y tablas -
Analysis 3.5

Comparison 3 Death at five years, Outcome 5 Uterine cancer ‐ best case scenario.

Comparison 3 Death at five years, Outcome 6 Uterine cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 3.6

Comparison 3 Death at five years, Outcome 6 Uterine cancer ‐ worst case scenario.

Comparison 3 Death at five years, Outcome 7 Urinary bladder cancer.
Figuras y tablas -
Analysis 3.7

Comparison 3 Death at five years, Outcome 7 Urinary bladder cancer.

Comparison 4 Failure to control local tumour at three months, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 4.1

Comparison 4 Failure to control local tumour at three months, Outcome 1 Head and neck cancer.

Comparison 4 Failure to control local tumour at three months, Outcome 2 Head and neck cancer ‐ best case scenario.
Figuras y tablas -
Analysis 4.2

Comparison 4 Failure to control local tumour at three months, Outcome 2 Head and neck cancer ‐ best case scenario.

Comparison 4 Failure to control local tumour at three months, Outcome 3 Head and neck ‐ worst case scenario.
Figuras y tablas -
Analysis 4.3

Comparison 4 Failure to control local tumour at three months, Outcome 3 Head and neck ‐ worst case scenario.

Comparison 5 Local recurrence at one year, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 5.1

Comparison 5 Local recurrence at one year, Outcome 1 Head and neck cancer.

Comparison 5 Local recurrence at one year, Outcome 2 Head and neck cancer ‐ best case scenario.
Figuras y tablas -
Analysis 5.2

Comparison 5 Local recurrence at one year, Outcome 2 Head and neck cancer ‐ best case scenario.

Comparison 5 Local recurrence at one year, Outcome 3 Head and neck cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 5.3

Comparison 5 Local recurrence at one year, Outcome 3 Head and neck cancer ‐ worst case scenario.

Comparison 5 Local recurrence at one year, Outcome 4 Uterine cervix cancer.
Figuras y tablas -
Analysis 5.4

Comparison 5 Local recurrence at one year, Outcome 4 Uterine cervix cancer.

Comparison 5 Local recurrence at one year, Outcome 5 Uterine cervix cancer ‐ best case scenario.
Figuras y tablas -
Analysis 5.5

Comparison 5 Local recurrence at one year, Outcome 5 Uterine cervix cancer ‐ best case scenario.

Comparison 5 Local recurrence at one year, Outcome 6 Uterine cervix cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 5.6

Comparison 5 Local recurrence at one year, Outcome 6 Uterine cervix cancer ‐ worst case scenario.

Comparison 6 Local recurrence at two years, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 6.1

Comparison 6 Local recurrence at two years, Outcome 1 Head and neck cancer.

Comparison 6 Local recurrence at two years, Outcome 2 Uterine cervix cancer.
Figuras y tablas -
Analysis 6.2

Comparison 6 Local recurrence at two years, Outcome 2 Uterine cervix cancer.

Comparison 7 Local recurrence at five years, Outcome 1 Head and neck cancer.
Figuras y tablas -
Analysis 7.1

Comparison 7 Local recurrence at five years, Outcome 1 Head and neck cancer.

Comparison 7 Local recurrence at five years, Outcome 2 Head and neck cancer ‐ best case scenario.
Figuras y tablas -
Analysis 7.2

Comparison 7 Local recurrence at five years, Outcome 2 Head and neck cancer ‐ best case scenario.

Comparison 7 Local recurrence at five years, Outcome 3 Head and neck cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 7.3

Comparison 7 Local recurrence at five years, Outcome 3 Head and neck cancer ‐ worst case scenario.

Comparison 7 Local recurrence at five years, Outcome 4 Uterine cervix cancer.
Figuras y tablas -
Analysis 7.4

Comparison 7 Local recurrence at five years, Outcome 4 Uterine cervix cancer.

Comparison 7 Local recurrence at five years, Outcome 5 Uterine cervix cancer ‐ best case scenario.
Figuras y tablas -
Analysis 7.5

Comparison 7 Local recurrence at five years, Outcome 5 Uterine cervix cancer ‐ best case scenario.

Comparison 7 Local recurrence at five years, Outcome 6 Uterine cervix cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 7.6

Comparison 7 Local recurrence at five years, Outcome 6 Uterine cervix cancer ‐ worst case scenario.

Comparison 8 Metastases at one year, Outcome 1 Uterine cervix cancer.
Figuras y tablas -
Analysis 8.1

Comparison 8 Metastases at one year, Outcome 1 Uterine cervix cancer.

Comparison 9 Metastases at two years, Outcome 1 Uterine cervix cancer.
Figuras y tablas -
Analysis 9.1

Comparison 9 Metastases at two years, Outcome 1 Uterine cervix cancer.

Comparison 9 Metastases at two years, Outcome 2 Urinary bladder carcinoma.
Figuras y tablas -
Analysis 9.2

Comparison 9 Metastases at two years, Outcome 2 Urinary bladder carcinoma.

Comparison 9 Metastases at two years, Outcome 3 Carcinoma of the bronchus.
Figuras y tablas -
Analysis 9.3

Comparison 9 Metastases at two years, Outcome 3 Carcinoma of the bronchus.

Comparison 10 Metastases at five years, Outcome 1 Head and neck carcinoma.
Figuras y tablas -
Analysis 10.1

Comparison 10 Metastases at five years, Outcome 1 Head and neck carcinoma.

Comparison 10 Metastases at five years, Outcome 2 Uterine cervix cancer.
Figuras y tablas -
Analysis 10.2

Comparison 10 Metastases at five years, Outcome 2 Uterine cervix cancer.

Comparison 10 Metastases at five years, Outcome 3 Uterine cervix cancer ‐ best case scenario.
Figuras y tablas -
Analysis 10.3

Comparison 10 Metastases at five years, Outcome 3 Uterine cervix cancer ‐ best case scenario.

Comparison 10 Metastases at five years, Outcome 4 Uterine cervix cancer ‐ worst case scenario.
Figuras y tablas -
Analysis 10.4

Comparison 10 Metastases at five years, Outcome 4 Uterine cervix cancer ‐ worst case scenario.

Comparison 11 Adverse events, Outcome 1 Death through radiation tissue injury.
Figuras y tablas -
Analysis 11.1

Comparison 11 Adverse events, Outcome 1 Death through radiation tissue injury.

Comparison 11 Adverse events, Outcome 2 Severe radiation tissue injury.
Figuras y tablas -
Analysis 11.2

Comparison 11 Adverse events, Outcome 2 Severe radiation tissue injury.

Comparison 11 Adverse events, Outcome 3 Severe radiation tissue injury ‐ best case scenario.
Figuras y tablas -
Analysis 11.3

Comparison 11 Adverse events, Outcome 3 Severe radiation tissue injury ‐ best case scenario.

Comparison 11 Adverse events, Outcome 4 Severe radiation tissue injury ‐ worst case scenario.
Figuras y tablas -
Analysis 11.4

Comparison 11 Adverse events, Outcome 4 Severe radiation tissue injury ‐ worst case scenario.

Comparison 11 Adverse events, Outcome 5 Acute central nervous system oxygen toxicity.
Figuras y tablas -
Analysis 11.5

Comparison 11 Adverse events, Outcome 5 Acute central nervous system oxygen toxicity.

Comparison 11 Adverse events, Outcome 6 Acute central nervous system toxicity ‐ best case scenario.
Figuras y tablas -
Analysis 11.6

Comparison 11 Adverse events, Outcome 6 Acute central nervous system toxicity ‐ best case scenario.

Comparison 11 Adverse events, Outcome 7 Acute central nervous system toxicity ‐ worst case scenario.
Figuras y tablas -
Analysis 11.7

Comparison 11 Adverse events, Outcome 7 Acute central nervous system toxicity ‐ worst case scenario.

Comparison 11 Adverse events, Outcome 8 Middle ear barotrauma.
Figuras y tablas -
Analysis 11.8

Comparison 11 Adverse events, Outcome 8 Middle ear barotrauma.

Comparison 1. Death at one year

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

9

710

Risk Ratio (M‐H, Random, 95% CI)

0.83 [0.70, 0.98]

1.1 12 or fewer fractions each group

5

412

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.74, 1.17]

1.2 12 or fewer fractions with HBOT, more than 12 with control

4

281

Risk Ratio (M‐H, Random, 95% CI)

0.66 [0.41, 1.08]

1.3 More than 12 fractions each group

1

17

Risk Ratio (M‐H, Random, 95% CI)

0.59 [0.13, 2.70]

2 Head and neck ‐ best case scenario Show forest plot

9

743

Risk Ratio (M‐H, Random, 95% CI)

0.73 [0.62, 0.85]

2.1 12 or fewer fractions each group

5

439

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.64, 1.02]

2.2 12 or fewer fractions with HBOT, more than 12 with control

4

287

Risk Ratio (M‐H, Random, 95% CI)

0.63 [0.43, 0.91]

2.3 More than 12 fractions each group

1

17

Risk Ratio (M‐H, Random, 95% CI)

0.59 [0.13, 2.70]

3 Head and neck ‐ worst case scenario Show forest plot

9

743

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.76, 1.15]

3.1 12 or fewer fractions each group

5

439

Risk Ratio (M‐H, Random, 95% CI)

1.10 [0.90, 1.36]

3.2 12 or fewer fractions with HBOT, more than 12 with control

4

287

Risk Ratio (M‐H, Random, 95% CI)

0.71 [0.45, 1.13]

3.3 More than 12 fractions each group

1

17

Risk Ratio (M‐H, Random, 95% CI)

0.59 [0.13, 2.70]

4 Uterine cervix cancer Show forest plot

4

728

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.69, 1.11]

4.1 12 or fewer fractions each groups

3

329

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.70, 1.38]

4.2 More than 12 fractions each group

3

399

Risk Ratio (M‐H, Fixed, 95% CI)

0.79 [0.57, 1.10]

5 Uterine cervix ‐ best case scenario Show forest plot

4

732

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.69, 1.10]

6 Uterine cervix ‐ worst case scenario Show forest plot

4

732

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.72, 1.15]

7 Urinary bladder cancer Show forest plot

4

330

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.74, 1.27]

7.1 12 or fewer fractions each group

1

16

Risk Ratio (M‐H, Fixed, 95% CI)

0.2 [0.03, 1.35]

7.2 12 or fewer fractions with HBOT, more than 12 with control

1

38

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.44, 1.51]

7.3 More than 12 fractions each group

1

40

Risk Ratio (M‐H, Fixed, 95% CI)

1.43 [0.68, 3.00]

7.4 Mixed fractionation scheme

1

236

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.73, 1.44]

8 Urinary bladder ‐ best case scenario Show forest plot

4

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.71, 1.21]

9 Urinary bladder ‐ worst case scenario Show forest plot

4

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.78, 1.34]

10 Bronchial cancer Show forest plot

1

49

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.72, 1.64]

11 Rectal cancer Show forest plot

1

4

Risk Ratio (M‐H, Fixed, 95% CI)

1.67 [0.48, 5.76]

12 Oesphageal cancer Show forest plot

1

4

Risk Ratio (M‐H, Fixed, 95% CI)

0.6 [0.17, 2.07]

13 Gliobastoma Show forest plot

1

4

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figuras y tablas -
Comparison 1. Death at one year
Comparison 2. Death at two years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

3

189

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.83, 1.12]

1.1 12 or fewer fractions in each group

1

48

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.76, 1.40]

1.2 12 or fewer fractions with HBOT, more than 12 with control

1

124

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.79, 1.09]

1.3 More than 12 fractions in both HBOT and control

1

17

Risk Ratio (M‐H, Fixed, 95% CI)

1.19 [0.37, 3.76]

2 Head and neck ‐ best case scenario Show forest plot

3

195

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.79, 1.07]

2.1 12 or fewer fractions in each group

1

48

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.76, 1.40]

2.2 12 or fewer fractions with HBOT, more than 12 with control

1

130

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.73, 1.03]

2.3 More than 12 fractions in both HBOT and control

1

17

Risk Ratio (M‐H, Fixed, 95% CI)

1.19 [0.37, 3.76]

3 Head and neck ‐ worst case scenario Show forest plot

3

195

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.86, 1.15]

3.1 12 or fewer fractions in each group

1

48

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.76, 1.40]

3.2 12 or fewer fractions with HBOT, more than 12 with control

1

130

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.83, 1.14]

3.3 More than 12 fractions in both HBOT and control

1

17

Risk Ratio (M‐H, Fixed, 95% CI)

1.19 [0.37, 3.76]

4 Uterine cervix cancer Show forest plot

4

607

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.76, 1.15]

4.1 12 or fewer fractions in HBOT and control

1

71

Risk Ratio (M‐H, Random, 95% CI)

0.72 [0.47, 1.09]

4.2 More than 12 fractions in HBOT and control

4

536

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.81, 1.21]

5 Urinary bladder carcinoma Show forest plot

2

24

Risk Ratio (M‐H, Fixed, 95% CI)

1.57 [0.63, 3.92]

6 Urinary bladder ‐ best case Show forest plot

2

58

Risk Ratio (M‐H, Random, 95% CI)

0.47 [0.04, 5.24]

7 Urinary bladder ‐ worst case Show forest plot

2

58

Risk Ratio (M‐H, Fixed, 95% CI)

5.18 [2.18, 12.31]

Figuras y tablas -
Comparison 2. Death at two years
Comparison 3. Death at five years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

6

550

Risk Ratio (M‐H, Fixed, 95% CI)

0.82 [0.69, 0.98]

1.1 12 or fewer fractions each group

3

349

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.75, 1.22]

1.2 12 or fewer fractions in HBOT, more than 12 in control

4

201

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.53, 0.89]

2 Head and neck ‐ best case scenario Show forest plot

6

575

Risk Ratio (M‐H, Fixed, 95% CI)

0.77 [0.64, 0.92]

2.1 12 or fewer fractions in each group

3

368

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.69, 1.12]

2.2 12 or fewer fractions in HBOT, more than 12 in control

4

207

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.51, 0.85]

3 Head and neck ‐ worst case scenario Show forest plot

6

575

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.81, 1.13]

3.1 12 or fewer fractions each group

3

368

Risk Ratio (M‐H, Fixed, 95% CI)

1.15 [0.92, 1.45]

3.2 12 or fewer fractions in HBOT, more than 12 in control

4

207

Risk Ratio (M‐H, Fixed, 95% CI)

0.75 [0.59, 0.96]

4 Uterine cervix cancer Show forest plot

4

772

Risk Ratio (M‐H, Random, 95% CI)

0.95 [0.80, 1.14]

4.1 12 or fewer fractions each group

3

329

Risk Ratio (M‐H, Random, 95% CI)

0.91 [0.62, 1.34]

4.2 More than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.81, 1.15]

4.3 12 or fewer fractions in HBOT versus more than 12 in control

1

58

Risk Ratio (M‐H, Random, 95% CI)

1.06 [0.70, 1.61]

5 Uterine cancer ‐ best case scenario Show forest plot

4

783

Risk Ratio (M‐H, Random, 95% CI)

0.92 [0.77, 1.09]

5.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Random, 95% CI)

0.88 [0.61, 1.28]

5.2 More than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.81, 1.15]

5.3 12 or fewer fractions in HBOT versus more than 12 in control

1

65

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.57, 1.32]

6 Uterine cancer ‐ worst case scenario Show forest plot

4

783

Risk Ratio (M‐H, Random, 95% CI)

0.98 [0.81, 1.18]

6.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.63, 1.38]

6.2 More than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.81, 1.15]

6.3 12 or fewer fractions in HBOT versus more than 12 in control

1

65

Risk Ratio (M‐H, Random, 95% CI)

1.18 [0.79, 1.77]

7 Urinary bladder cancer Show forest plot

1

236

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.88, 1.22]

Figuras y tablas -
Comparison 3. Death at five years
Comparison 4. Failure to control local tumour at three months

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

5

446

Risk Ratio (M‐H, Random, 95% CI)

0.58 [0.39, 0.85]

1.1 12 or fewer fractions each group

5

420

Risk Ratio (M‐H, Random, 95% CI)

0.54 [0.34, 0.88]

1.2 Less than 12 fractions in HBOT group versus more than 12 in control

1

26

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.24, 1.82]

2 Head and neck cancer ‐ best case scenario Show forest plot

5

465

Risk Ratio (M‐H, Random, 95% CI)

0.57 [0.41, 0.78]

2.1 12 or fewer fractions in each group

5

439

Risk Ratio (M‐H, Random, 95% CI)

0.53 [0.36, 0.80]

2.2 Less than 12 fractions in HBOT versus more than 12 in control

1

26

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.24, 1.82]

3 Head and neck ‐ worst case scenario Show forest plot

5

465

Risk Ratio (M‐H, Random, 95% CI)

0.59 [0.35, 1.00]

3.1 12 or fewer fractions in each group

5

439

Risk Ratio (M‐H, Random, 95% CI)

0.56 [0.30, 1.05]

3.2 Less than 12 fractions in HBOT versus more than 12 in control

1

26

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.24, 1.82]

Figuras y tablas -
Comparison 4. Failure to control local tumour at three months
Comparison 5. Local recurrence at one year

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

5

582

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.56, 0.78]

1.1 12 or fewer fractions each group

3

355

Risk Ratio (M‐H, Fixed, 95% CI)

0.62 [0.50, 0.77]

1.2 12 or fewer fractions with HBOT, more than 12 with control

2

227

Risk Ratio (M‐H, Fixed, 95% CI)

0.73 [0.57, 0.94]

2 Head and neck cancer ‐ best case scenario Show forest plot

5

611

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.51, 0.71]

2.1 12 or fewer fractions in each group

3

374

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.45, 0.70]

2.2 12 or fewer fractions with HBOT, more than 12 with control

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.53, 0.87]

3 Head and neck cancer ‐ worst case scenario Show forest plot

5

611

Risk Ratio (M‐H, Fixed, 95% CI)

0.75 [0.65, 0.87]

3.1 12 or fewer fractions in each group

3

374

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.60, 0.87]

3.2 12 or fewer fractions with HBOT, more than 12 with control

2

237

Risk Ratio (M‐H, Fixed, 95% CI)

0.81 [0.64, 1.03]

4 Uterine cervix cancer Show forest plot

3

714

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.63, 1.06]

4.1 12 or fewer fractions each group

3

329

Risk Ratio (M‐H, Random, 95% CI)

0.85 [0.57, 1.27]

4.2 more than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.49, 1.28]

5 Uterine cervix cancer ‐ best case scenario Show forest plot

3

718

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.63, 1.02]

5.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Random, 95% CI)

0.82 [0.58, 1.17]

5.2 More than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.49, 1.28]

6 Uterine cervix cancer ‐ worst case scenario Show forest plot

3

718

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.63, 1.19]

6.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.56, 1.58]

6.2 More than 12 fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.49, 1.28]

Figuras y tablas -
Comparison 5. Local recurrence at one year
Comparison 6. Local recurrence at two years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

1

48

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.60, 1.14]

2 Uterine cervix cancer Show forest plot

2

360

Risk Ratio (M‐H, Random, 95% CI)

0.60 [0.38, 0.97]

2.1 12 or fewer fractions in each group

1

71

Risk Ratio (M‐H, Random, 95% CI)

0.53 [0.37, 0.77]

2.2 More than 12 fractions in each group

2

289

Risk Ratio (M‐H, Random, 95% CI)

0.68 [0.26, 1.73]

Figuras y tablas -
Comparison 6. Local recurrence at two years
Comparison 7. Local recurrence at five years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck cancer Show forest plot

5

495

Risk Ratio (M‐H, Random, 95% CI)

0.77 [0.62, 0.95]

1.1 12 or fewer fractions in each group

2

324

Risk Ratio (M‐H, Random, 95% CI)

0.74 [0.62, 0.88]

1.2 12 or fewer fractions in HBOT, more than 12 in control

3

171

Risk Ratio (M‐H, Random, 95% CI)

0.75 [0.39, 1.43]

2 Head and neck cancer ‐ best case scenario Show forest plot

5

521

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.57, 0.86]

2.1 12 or fewer fractions in each group

2

343

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.52, 0.94]

2.2 12 or fewer fractions in HBOT, more than 12 in control

3

178

Risk Ratio (M‐H, Random, 95% CI)

0.70 [0.43, 1.12]

3 Head and neck cancer ‐ worst case scenario Show forest plot

5

521

Risk Ratio (M‐H, Random, 95% CI)

0.84 [0.66, 1.06]

3.1 12 or fewer fractions in each group

2

343

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.69, 0.95]

3.2 12 or fewer fractions in HBOT, more than 12 in control

3

178

Risk Ratio (M‐H, Random, 95% CI)

0.80 [0.38, 1.71]

4 Uterine cervix cancer Show forest plot

4

772

Risk Ratio (M‐H, Random, 95% CI)

0.85 [0.65, 1.13]

4.1 12 or fewer fractions each group

3

329

Risk Ratio (M‐H, Random, 95% CI)

0.83 [0.49, 1.41]

4.2 12 or fewer fractions in HBOT group versus more than 12 fractions in control

1

58

Risk Ratio (M‐H, Random, 95% CI)

1.25 [0.58, 2.71]

4.3 12 or more fractions in each group

2

385

Risk Ratio (M‐H, Random, 95% CI)

0.83 [0.52, 1.32]

5 Uterine cervix cancer ‐ best case scenario Show forest plot

4

783

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.72, 0.97]

5.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.85 [0.70, 1.05]

5.2 12 or fewer fractions in HBOT, more than 12 in controls

2

385

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.64, 1.01]

5.3 More than 12 fractions in each group

1

65

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.44, 1.89]

6 Uterine cervix cancer ‐ worst case scenario Show forest plot

4

783

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.76, 1.03]

6.1 12 or fewer fractions in each group

3

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.74, 1.10]

6.2 12 or fewer fracxtions in HBOT, more than 12 in controls

2

385

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.64, 1.01]

6.3 More than 12 fractions in each group

1

65

Risk Ratio (M‐H, Fixed, 95% CI)

1.60 [0.78, 3.28]

Figuras y tablas -
Comparison 7. Local recurrence at five years
Comparison 8. Metastases at one year

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Uterine cervix cancer Show forest plot

1

320

Risk Ratio (M‐H, Fixed, 95% CI)

0.79 [0.52, 1.19]

1.1 10 or fewer fractions

1

71

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.35, 2.73]

1.2 11 or more fractions

1

249

Risk Ratio (M‐H, Fixed, 95% CI)

0.75 [0.48, 1.19]

Figuras y tablas -
Comparison 8. Metastases at one year
Comparison 9. Metastases at two years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Uterine cervix cancer Show forest plot

3

522

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.84, 1.31]

1.1 More than 12 fractions in each group

3

522

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.84, 1.31]

2 Urinary bladder carcinoma Show forest plot

2

80

Risk Ratio (M‐H, Fixed, 95% CI)

2.0 [0.58, 6.91]

3 Carcinoma of the bronchus Show forest plot

1

49

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.60, 1.80]

Figuras y tablas -
Comparison 9. Metastases at two years
Comparison 10. Metastases at five years

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Head and neck carcinoma Show forest plot

1

50

Risk Ratio (M‐H, Fixed, 95% CI)

0.46 [0.09, 2.30]

2 Uterine cervix cancer Show forest plot

3

456

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.50, 1.26]

2.1 12 or fewer fractions each group

2

149

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.45, 0.99]

2.2 12 or fewer fractions in HBOT group versus more than 12 fractions in control

1

58

Risk Ratio (M‐H, Random, 95% CI)

0.07 [0.00, 1.12]

2.3 More than 12 fractions in each group

1

249

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.78, 1.26]

3 Uterine cervix cancer ‐ best case scenario Show forest plot

3

467

Risk Ratio (M‐H, Random, 95% CI)

0.76 [0.46, 1.26]

3.1 12 or fewer fractions in each group

2

153

Risk Ratio (M‐H, Random, 95% CI)

0.66 [0.45, 0.98]

3.2 12 or fewer fractions in HBOT versus more than 12 in control

1

65

Risk Ratio (M‐H, Random, 95% CI)

0.05 [0.00, 0.79]

3.3 More than 12 fractions in each group

1

249

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.78, 1.26]

4 Uterine cervix cancer ‐ worst case scenario Show forest plot

3

467

Risk Ratio (M‐H, Random, 95% CI)

0.85 [0.56, 1.31]

4.1 12 or fewer fractions in each group

2

153

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.35, 2.68]

4.2 12 or fewer fractions in HBOT versus more than 12 in control

1

65

Risk Ratio (M‐H, Random, 95% CI)

0.39 [0.11, 1.38]

4.3 More than 12 fractions in each group

1

249

Risk Ratio (M‐H, Random, 95% CI)

0.99 [0.78, 1.26]

Figuras y tablas -
Comparison 10. Metastases at five years
Comparison 11. Adverse events

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Death through radiation tissue injury Show forest plot

2

633

Risk Ratio (M‐H, Fixed, 95% CI)

1.64 [0.89, 3.03]

2 Severe radiation tissue injury Show forest plot

7

779

Risk Ratio (M‐H, Fixed, 95% CI)

2.35 [1.66, 3.33]

3 Severe radiation tissue injury ‐ best case scenario Show forest plot

7

803

Risk Ratio (M‐H, Fixed, 95% CI)

1.94 [1.39, 2.69]

4 Severe radiation tissue injury ‐ worst case scenario Show forest plot

7

803

Risk Ratio (M‐H, Fixed, 95% CI)

2.69 [1.92, 3.77]

5 Acute central nervous system oxygen toxicity Show forest plot

4

331

Risk Ratio (M‐H, Fixed, 95% CI)

6.76 [1.16, 39.31]

5.1 12 or fewer oxygen fractions

3

242

Risk Ratio (M‐H, Fixed, 95% CI)

4.30 [0.47, 39.60]

5.2 More than 12 oxygen fractions

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

10.76 [0.61, 188.98]

6 Acute central nervous system toxicity ‐ best case scenario Show forest plot

4

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.00 [0.81, 11.10]

6.1 12 or fewer oxygen fractions

3

248

Risk Ratio (M‐H, Fixed, 95% CI)

1.30 [0.26, 6.53]

6.2 More than 12 oxygen fractions

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

10.76 [0.61, 188.98]

7 Acute central nervous system toxicity ‐ worst case scenario Show forest plot

4

337

Risk Ratio (M‐H, Fixed, 95% CI)

9.74 [1.73, 54.98]

7.1 12 or fewer oxygen fractions

3

248

Risk Ratio (M‐H, Fixed, 95% CI)

9.12 [1.05, 79.50]

7.2 More than 12 oxygen fractions

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

10.76 [0.61, 188.98]

8 Middle ear barotrauma Show forest plot

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

6.85 [0.36, 128.83]

Figuras y tablas -
Comparison 11. Adverse events